These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30178833)

  • 41. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer.
    Tsutsui S; Yasuda K; Suzuki K; Takeuchi H; Nishizaki T; Higashi H; Era S
    BMC Cancer; 2006 Jul; 6():187. PubMed ID: 16839413
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prognostic significance of expression of p53, bcl-2 and bax in squamous epithelial carcinoma of the larynx--a multivariate analysis].
    Jäckel MC; Sellmann L; Youssef S; Dorudian MA; Füzesi L
    HNO; 2001 Mar; 49(3):204-11. PubMed ID: 11320623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Expression of apoptosis and proliferation markers in progression of ovarian cancer].
    Antoneeva II; Petrov SB
    Patol Fiziol Eksp Ter; 2008; (4):6-7. PubMed ID: 19198263
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High α B-crystallin and p53 co-expression is associated with poor prognosis in ovarian cancer.
    Tan L; Sha L; Hou N; Zhang M; Ma Q; Shi C
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31152111
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic significance of HER-2, p53 and Bcl-2 in patients with epithelial ovarian cancer.
    Malamou-Mitsi V; Crikoni O; Timotheadou E; Aravantinos G; Vrettou E; Agnantis N; Fountzilas G
    Anticancer Res; 2007; 27(2):1157-65. PubMed ID: 17465257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tomm34 is commonly expressed in epithelial ovarian cancer and associates with tumour type and high FIGO stage.
    Muller P; Coates PJ; Nenutil R; Trcka F; Hrstka R; Chovanec J; Brychtova V; Vojtesek B
    J Ovarian Res; 2019 Mar; 12(1):30. PubMed ID: 30917858
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The prognostic and predictive value of ERCC-1, p53, bcl-2 and bax in epithelial ovarian cancer.
    Avraam K; Pavlakis K; Papadimitriou C; Vrekoussis T; Panoskaltsis T; Messini I; Patsouris E
    Eur J Gynaecol Oncol; 2011; 32(5):516-20. PubMed ID: 22053665
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic significance of Bcl-2 and p53 expression in gastric cancer.
    Lee HK; Lee HS; Yang HK; Kim WH; Lee KU; Choe KJ; Kim JP
    Int J Colorectal Dis; 2003 Nov; 18(6):518-25. PubMed ID: 12811476
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The AIB1 gene polyglutamine repeat length polymorphism contributes to risk of epithelial ovarian cancer risk: a case-control study.
    Han G; Xie S; Fang H; Li G; Han Y; Qin Z
    Tumour Biol; 2015 Jan; 36(1):371-4. PubMed ID: 25263716
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of survivin, bcl-2, P53 and bax in breast carcinoma and ductal intraepithelial neoplasia (DIN 1a).
    Kayaselcuk F; Nursal TZ; Polat A; Noyan T; Yildirim S; Tarim A; Seydaoglu G
    J Exp Clin Cancer Res; 2004 Mar; 23(1):105-12. PubMed ID: 15149158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Upregulation of cyclase-associated actin cytoskeleton regulatory protein 2 in epithelial ovarian cancer correlates with aggressive histologic types and worse outcomes.
    Adachi M; Masugi Y; Yamazaki K; Emoto K; Kobayashi Y; Tominaga E; Banno K; Aoki D; Sakamoto M
    Jpn J Clin Oncol; 2020 Jun; 50(6):643-652. PubMed ID: 32211793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. p53 and related proteins in epithelial ovarian cancer.
    Sengupta PS; McGown AT; Bajaj V; Blackhall F; Swindell R; Bromley M; Shanks JH; Ward T; Buckley CH; Reynolds K; Slade RJ; Jayson GC
    Eur J Cancer; 2000 Dec; 36(18):2317-28. PubMed ID: 11094305
    [TBL] [Abstract][Full Text] [Related]  

  • 53. THE PROGNOSTIC SIGNIFICANCE OF P53, BCL2 AND MIB1 EXPRESSIONS RELATED WITH OTHER CLINICOPATHOLOGICAL VARIABLES IN SEROUS OVARIAN CARCINOMAS. A CLINICOPATHOLOGICAL STUDY IN PERITONEAL FLUIDS.
    Kalogeraki A; Tamiolakis D; Matalliotaki C; Karvela-Kalogeraki I; Karvelas-Kalogerakis M; Segredakis J; Sinatkas V; Matalliotakis I
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):454-60. PubMed ID: 26204652
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of pro-apoptotic (p53, p21, bax, bak and fas) and anti-apoptotic (bcl-2 and bcl-x) proteins in serous versus mucinous borderline ovarian tumours.
    Fauvet R; Dufournet C; Poncelet C; Uzan C; Hugol D; Daraï E
    J Surg Oncol; 2005 Dec; 92(4):337-43. PubMed ID: 16299808
    [TBL] [Abstract][Full Text] [Related]  

  • 55. bcl-2 protein expression is associated with a prognostically favourable phenotype in breast cancer irrespective of p53 immunostaining.
    Nakopoulou L; Michalopoulou A; Giannopoulou I; Tzonou A; Keramopoulos A; Lazaris AC; Davaris PS
    Histopathology; 1999 Apr; 34(4):310-9. PubMed ID: 10231398
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Steroid receptors and hormones in relation to cell proliferation and apoptosis in poorly differentiated epithelial ovarian tumors.
    Lindgren P; Bäckström T; Mählck CG; Ridderheim M; Cajander S
    Int J Oncol; 2001 Jul; 19(1):31-8. PubMed ID: 11408919
    [TBL] [Abstract][Full Text] [Related]  

  • 57. p53 and mdm2 as prognostic indicators in patients with epithelial ovarian cancer: a multivariate analysis.
    Dogan E; Saygili U; Tuna B; Gol M; Gürel D; Acar B; Koyuncuoğlu M
    Gynecol Oncol; 2005 Apr; 97(1):46-52. PubMed ID: 15790436
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of c-kit and ki-67 expression on patients prognosis in advanced ovarian serous carcinoma.
    Khalifeh I; Munkarah AR; Schimp V; Morris R; Lawrence WD; Ali-Fehmi R
    Int J Gynecol Pathol; 2005 Jul; 24(3):228-34. PubMed ID: 15968197
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of Interactive Genes Associated with Apoptosis and Their Prognostic Value for Ovarian Serous Adenocarcinoma.
    Shin K; Kim KH; Yoon MS; Suh DS; Lee JY; Kim A; Eo W
    Adv Clin Exp Med; 2016; 25(3):513-21. PubMed ID: 27629740
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The study of the expression, effect and clinical relationship of TGF-beta1 CD44V6 bcl-2 and p53 in the larynx squamous carcinoma].
    Huang Z; Deng H; Feng X; Zhang F; Jiang J; Liu D
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Dec; 18(12):733-6. PubMed ID: 15831046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.